Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Retrospective analysis of safety and efficacy of enhanced recovery pathways in stage II–III colorectal cancer patients submitted to surgery and adjuvant therapy

Fig. 5

European Organization for Research and Treatment questionnaires score. The mean differences in QLQ-C30/CR38 (quality of life questionnaires-cancer specific 30/colorectal cancer specific 38) score of 10 or more points was considered as clinically significant difference. *Clinically significant lower QLQ-C30/CR38 score/patient than those of FTLCO cohort

Back to article page